LSTA FY 2019 Earnings — Lisata Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

LSTALisata Therapeutics, Inc.

$44M

FY 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$65,000

Operating Income

-$20M

Net Income

-$20M

EPS (Diluted)

$-29.20

Cash Flow

Operating Cash Flow

-$19M

Free Cash Flow

-$19M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$27M

Total Liabilities

$7M

Stockholders' Equity

$21M

Cash & Equivalents

$14M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$65,000	-$225,000	+71.1%
Operating Income	-$20M	-$17M	-18.3%
Net Income	-$20M	-$16M	-24.3%